Chemotherapy Without Acute Leukemia As Secondary Diagnosis with Cc in Pennsylvania
MS-DRG 847: Chemotherapy without acute leukemia as secondary diagnosis with cc
$80,595typical hospital bill
$15,718typical amount paid
$11,018–$21,929range paid across 11 hospitals
Pennsylvania hospitals billed Medicare a typical $80,595 for this stay in 2024, about 5.1 times what was actually paid. Medicare's payment depends mostly on the hospital's location and teaching role; the bill depends on the hospital's own price list, so bills vary far more than payments.
Billed (list price)Actually paid (Medicare + patient)
| Hospital | City | Medicare stays | Billed | Paid | |
|---|---|---|---|---|---|
| Lehigh Valley Hospital | Allentown | 36 | $53,362 | $11,018 | |
| Geisinger Wyoming Valley Medical Center | Wilkes Barre | 16 | $81,497 | $11,294 | |
| Upmc Presbyterian Shadyside | Pittsburgh | 56 | $119,676 | $13,630 | |
| West Penn Hospital | Pittsburgh | 17 | $80,595 | $13,693 | |
| Milton S Hershey Medical Center | Hershey | 46 | $61,376 | $13,897 | |
| Geisinger Medical Center | Danville | 31 | $80,186 | $15,718 | |
| Thomas Jefferson University Hospital | Philadelphia | 34 | $48,922 | $15,747 | |
| Pennsylvania Hospital | Philadelphia | 11 | $97,654 | $16,680 | |
| Hospital of Univ of Pennsylvania | Philadelphia | 108 | $105,511 | $18,272 | |
| Lancaster General Hospital | Lancaster | 11 | $49,434 | $19,006 | |
| Temple University Hospital | Philadelphia | 13 | $281,362 | $21,929 |
Medicare: CMS, 2024 (hospitals with 11 or more Medicare stays). Cash and insurer prices: hospitals' own price files, where read; insurer figures are commercial plans only, median and 10th–90th percentile across plans.